Furthermore, the study showed that NUP85 interacted with CCR2 to regulate the PI3K/AKT signaling pathway, thus affecting lipid accumulation and inflammation in NAFLD. Here, NUP85 is linked to metabolic dysfunction-associated steatotic liver disease.